Showing posts sorted by relevance for query SMOKING. Sort by date Show all posts
Showing posts sorted by relevance for query SMOKING. Sort by date Show all posts

Tuesday, October 19, 2021

UC San Diego study: E-cigarettes don’t help smokers stay off cigarettes


Cigarette smokers who quit smoking but substitute e-cigarettes, or other tobacco product, are more likely to relapse


Peer-Reviewed Publication

UNIVERSITY OF CALIFORNIA - SAN DIEGO

John Pierce 

IMAGE: JOHN P. PIERCE, PH.D., DISTINGUISHED PROFESSOR AT THE HERBERT WERTHEIM SCHOOL OF PUBLIC HEALTH AND HUMAN LONGEVITY SCIENCE AT UC SAN DIEGO view more 

CREDIT: UNIVERSITY OF CALIFORNIA SAN DIEGO

The United States Centers for Disease Control and Prevention have suggested that smokers who are unable to quit smoking may benefit by switching from smoking cigarettes to vaping e-cigarettes if they switch completely and are able to avoid relapsing to cigarette smoking.

However, there have been few studies on whether smokers are able to transition to e-cigarettes—battery-operated devices that heat a liquid made of nicotine, flavorings and other chemicals to make an aerosol that users inhale into their lungs—without relapsing back to cigarette smoking.

Published in the Oct. 19, 2021 online issue of JAMA Network Open, an analysis by the Herbert Wertheim School of Public Health and Human Longevity Science at University of California San Diego and UC San Diego Moores Cancer Center reports that e-cigarette use—even on a daily basis—did not help smokers successfully stay off cigarettes.

“Our findings suggest that individuals who quit smoking and switched to e-cigarettes or other tobacco products actually increased their risk of a relapse back to smoking over the next year by 8.5 percentage points compared to those who quit using all tobacco products,” said first author John P. Pierce, Ph.D., Distinguished Professor at the Herbert Wertheim School of Public Health and UC San Diego Moores Cancer Center.

“Quitting is the most important thing a smoker can do to improve their health, but the evidence indicates that switching to e-cigarettes made it less likely, not more likely, to stay off of cigarettes.”

Researchers used data from the nationally representative Population Assessment of Tobacco and Health (PATH) longitudinal study, undertaken by the National Institute on Drug Abuse (NIDA) and the FDA Center for Tobacco Products under contract with Westat. The team identified 13,604 smokers between in 2013 and 2015 who were followed over two sequential annual surveys to explore changes in use of 12 tobacco products.

At the first annual follow up, 9.4% of these established smokers had quit. Now considered “former smokers,” 62.9% of these individuals remained tobacco free, while 37.1% had switched to another form of tobacco use. Of these recent smokers who switched to another product, 22.8% used e-cigarettes, with 17.6% of switchers using e-cigarettes daily.

Recent former smokers who switched to e-cigarettes were more likely to be non-Hispanic white, have higher incomes, have higher tobacco dependence scores and view e-cigarettes as less harmful than traditional cigarettes.

“Our goal in this study was to assess whether recent former smokers who had switched to e-cigarettes or another tobacco product were less likely to relapse to cigarette smoking compared to those who remained tobacco free,” said senior author Karen Messer, Ph.D., professor and chief of the Division of Biostatistics at the Herbert Wertheim School of Public Health.

At the second annual follow up, the authors compared the former smokers who were tobacco free to those who had switched to e-cigarettes or other tobacco products. Individuals who switched to any other form of tobacco use, including e-cigarettes, were more likely to relapse compared to former smokers who had quit all tobacco, by a total of 8.5 percentage points.

Among recent former smokers who abstained from all tobacco products, 50% were 12 or more months off cigarettes at the second follow up and were considered to have successfully quit smoking; this compared to 41.5% of recent former smokers who switched to any other form of tobacco use, including e-cigarettes.

While individuals who switched were more likely to relapse to smoking, they were also more likely to attempt to quit again and be off cigarettes for at least three months at the second follow up. A further follow-up survey is needed to identify whether this is evidence of a pattern of chronic quitting and relapsing to cigarette smoking, or whether it is part of progress toward successful quitting, said the researchers.

“This is the first study to take a deep look at whether switching to a less harmful nicotine source can be maintained over time without relapsing to cigarette smoking,” said Pierce. “If switching to e-cigarettes was a viable way to quit cigarette smoking, then those who switched to e-cigarettes should have much lower relapse rates to cigarette smoking. We found no evidence of this.”

Co-authors include: Ruifeng Chen, Sheila Kealey, Eric C. Leas, Martha M. White, Matthew D. Stone, Sara B. McMenamin, Dennis R. Trinidad, David R. Strong and Tarik Benmarhnia, all of UC San Diego.

This research was funded, in part, by the National Institutes of Health (1R01CA234539) and the Tobacco-Related Disease Research Program of the University of California Office of the President (28IR-0066).

Disclosures: The authors report no conflicts of interest.

Full study when embargo lifts: http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2021.28810?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=101921

Monday, August 29, 2022

Smoking is even more damaging to the heart than previously thought

Reports and Proceedings

EUROPEAN SOCIETY OF CARDIOLOGY

Barcelona, Spain – 25 Aug 2022: Smokers have weaker hearts than non-smokers, according to research presented at ESC Congress 2022.1 The study found that the more people smoked, the worse their heart function became. Some function was restored when people kicked the habit.

“It is well known that smoking causes blocked arteries, leading to coronary heart disease and stroke,” said study author Dr. Eva Holt of Herlev and Gentofte Hospital, Copenhagen, Denmark. “Our study shows that smoking also leads to thicker, weaker hearts. It means that smokers have a smaller volume of blood in the left heart chamber and less power to pump it out to the rest of the body. The more you smoke, the worse your heart function becomes. The heart can recuperate to some degree with smoking cessation, so it is never too late to quit.”

According to the World Health Organization, tobacco kills more than eight million people each year.2 Cigarette smoking is responsible for 50% of all avoidable deaths in smokers, with half of these due to atherosclerotic cardiovascular diseases such as heart attack and stroke.3 The detrimental effects of smoking on the arteries and arterial diseases such as heart attack and stroke are well established.4

Studies have also shown that smoking is associated with a higher risk of heart failure, where the heart muscle does not pump blood around the body as well as it should, usually because it is too weak or stiff. This means that the body does not receive the oxygen and nutrients it needs to work normally. The link between smoking and heart structure and function has not been fully examined. This study therefore explored whether smoking was related to changes in the structure and function of the heart in people without cardiovascular disease, and the effect of changing smoking habits.

The study used data from the 5th Copenhagen City Heart Study which investigated cardiovascular risk factors and diseases in the general population. A total of 3,874 participants aged 20 to 99 years without heart disease were enrolled. A self-administered questionnaire was used to obtain information on smoking history and to estimate pack-years, which is the number of cigarettes smoked through life. One pack-year is defined as 20 cigarettes smoked every day for one year.

Participants had an ultrasound of the heart, called echocardiography, which provides information about its structure and how well it is working. The researchers compared the echocardiography measures of current smokers versus never smokers after adjusting for age, sex, body mass index, hypertension, high cholesterol, diabetes and lung function.

The average age of participants was 56 years and 43% were women. Nearly one in five participants were current smokers (18.6%), while 40.9% were former smokers and 40.5% had never smoked. Compared to never smokers, current smokers had thicker, weaker and heavier hearts. Increasing pack-years were associated with pumping less blood. Dr. Holt explained: “We found that current smoking and accumulated pack-years were associated with worsening of the structure and function of the left heart chamber – the most important part of the heart. Furthermore, we found that over a 10-year period, those who continued smoking developed thicker, heavier and weaker hearts that were less able to pump blood compared to never smokers and those who quit during that time.”

She concluded: “Our study indicates that smoking not only damages the blood vessels but also directly harms the heart. The good news is that some of the damage is reversible by giving up.”

 

ENDS

 

Notes to editors

Email: press@escardio.org


The hashtag for ESC Congress 2022 is #ESCCongress.

Follow us on Twitter @ESCardioNews 


Funding: The Copenhagen City Heart Study is funded by The Danish Heart Foundation and The Metropolitan Region of Denmark.

 

Disclosures: Tor Biering-Sørensen reports: Steering Committee member of the Amgen financed GALACTIC-HF trial. Chief investigator and steering committee chair of the Sanofi Pasteur financed “NUDGE- FLU” trial. Chief investigator and steering committee chair of the Sanofi Pasteur financed “DANFLU-1” trial. Chief investigator and steering committee chair of the Sanofi Pasteur financed “DANFLU-2” trial. Steering Committee member of “LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System” trial. Advisory Board: Sanofi Pasteur, Amgen and GSK. Speaker Honorarium: Novartis, Sanofi Pasteur and GSK. Research grants: GE Healthcare and Sanofi Pasteur. The remaining authors have nothing to disclose.

 

References and notes

1The abstract “The effects of smoking on cardiac structure and function in a general population” will be presented during the session Risk stratification with echocardiographic parameters on Friday 26 August at 10:15 to 11:00 CEST at Station 1.

2World Health Organization tobacco fact sheet: https://www.who.int/news-room/fact-sheets/detail/tobacco.

3Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42:3227–3337.

4Centers for Disease Control and Prevention smoking and cardiovascular disease fact sheet: https://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/pdfs/fs_smoking_CVD_508.pdf.

 

About the European Society of Cardiology

The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.

About ESC Congress 2022

It is the world’s largest gathering of cardiovascular professionals, disseminating ground-breaking science both onsite in Barcelona and online – from 26 to 29 August. Explore the scientific programme. More information is available from the ESC Press Office at press@escardio.org.


Public call for tougher restrictions on buying tobacco in Britain


Peer-Reviewed Publication

UNIVERSITY COLLEGE LONDON

People in Britain strongly support restricting the sale of tobacco near schools and raising the legal age of sale to 21, finds a new UCL-led study.

In collaboration with The University of Edinburgh and Cardiff University, the research, published in Tobacco Control, examined data from the Cancer Research UK and SPECTRUM*-funded Smoking Toolkit Study, which has surveyed approximately 1,700 adults each month from England since 2006, and 2,200 adults each month from England, Scotland and Wales, since 2020.

The researchers examined data from September 2021, which asked participants about their views on potential policies targeting the availability of tobacco and cigarettes.

The results indicated that most of those surveyed supported retailers having their license revoked if they sold tobacco products to those under-age (89.6%) and for restrictions on the sale of cigarettes and tobacco near schools (69.9%).

Meanwhile, half (49.2%) thought that the legal age of sale for cigarettes and tobacco should be raised to 21, compared with just under a third who were opposed to the idea (30.7%).

Participants were also in favour of reducing the number of retailers selling tobacco in neighbourhoods that already had a high density of tobacco retailers – with almost half (46.5%) showing their support, compared with less than a quarter (23.3%) who disagreed.

Lead author Dr Loren Kock (UCL Institute of Epidemiology & Health) said: “Our findings indicate that policies to restrict tobacco retail near schools, and for tobacco retailer licences would receive strong majority support from the British public if legislated.

“Raising the age of sale to 21 and reducing the number of tobacco retailers also received greater support than opposition.

“However, a substantial proportion of respondents report having no opinion either way on these policies, suggesting there is potential to grow public support through clearer communication on the evidence and benefits of these policies.

“Moreover, support for tobacco availability policy may grow, and opposition diminish, if policies are demonstrated to be effective, and as future generations grow up without cigarettes.”

There are around 6.9million adult cigarette smokers in the UK, who spend approximately £15.6billion a year on legal and illicit tobacco.

Currently the law prohibits the sale of tobacco products to those under the age of 18. And previous studies have shown that a ban on the sale of tobacco products near schools could stop children from taking up the habit.

In 2019, the UK Government set an objective for England to be smokefree by 2030, meaning only 5% of the population would smoke by then. However, a recent report by Dr Javed Khan OBE, highlighted that particularly poorer areas may struggle to reach this target unless the rate of decline of people who smoke is accelerated by 40% **.

Niamh Shortt, Personal Chair of Health Geographies, School of GeoSciences, University of Edinburgh, said: “Across the UK nations targets have been set to radically reduce the proportion of people that smoke over the next decade.

“This new research shows that the public strongly support the introduction of new measures needed to meet these ambitious targets, including reducing the local availability of tobacco products.

“Having wide scale public support to introduce restrictions on the sales of tobacco should embolden the UK and devolved governments to introduce new policies restricting access to tobacco, particularly amongst children, and ensure future generations are tobacco free.”

Study limitations

The use of cross-sectional observational data and potentially unmeasured covariates limits the ability to infer causality between included variables (namely sociodemographic and smoking and quitting characteristics) and support for policies. The sample sizes for the sub-group analyses in Scotland and Wales analyses may also be underpowered.

Data on support for tobacco availability were collected during one survey wave, and if further data were collected the results may change.

* SPECTRUM is a UK Prevention Research Partnership (UKPRP) consortium.

** https://www.gov.uk/government/publications/the-khan-review-making-smoking-obsolete/making-smoking-obsolete-summary

Thursday, August 17, 2023

Scientists discover cause of smoking addiction – and how to cure it

Joe Pinkstone
Tue, 15 August 2023 a

Smoking is the single biggest cause of cancer in the UK

A cure for smoking could be on the horizon after scientists discovered how the brain becomes addicted to nicotine.

Smoking is the single biggest cause of cancer in the UK and is responsible for more than a quarter of all cancer deaths.

University of Cambridge scientists studied brain scans of more than 800 people taken when they were 14, 19 and 24 and analysed any impact smoking had.

They found that smokers were more likely to have a smaller region in the frontal lobe called the left ventromedial prefrontal cortex.

This part of the brain is linked to rule breaking and the study suggests people with a naturally smaller lobe are likely more inclined to break rules and be a renegade.

However, data also show that the right-hand side of the same brain region is also affected by smoking. This section is involved in controlling willpower and triggering feelings of pleasure and the scans reveal it shrinks in smokers.

“There was a reduction in brain grey matter volume in the left ventromedial prefrontal cortex which likely causes impulsive behaviour and rule breaking that leads to the initiation of cigarette smoking,” study author Prof Barbara Sahakian, from the University of Cambridge, told The Telegraph.

“Cigarette smoking leads to reductions in brain grey matter volume in the right ventromedial prefrontal cortex, which is associated with sensation seeking and pleasurable experiences that reinforces and maintains future cigarette smoking. This eventually leads to addiction.”

The study, published in Nature Communications, looked at any brain changes that happened after people started smoking and found nicotine was associated with significant changes.

Vaping addiction

Although the study only looked at smoking of cigarettes the scientists think the changes in the brain could also be caused by vaping.

“The nicotine effect we found with smoking cigarettes may also apply to e-cigarettes,” Prof Sahakian told The Telegraph. “Both e-cigarettes and regular cigarettes contain nicotine. Nicotine is highly addictive. There is an increasing concern about adolescents becoming addicted to vaping.”

The scientists believe they have discovered a “neurological mechanism” which underpins how people start smoking and what makes it so hard to quit.

The team says that now they know where, and how, nicotine is warping the mind then it could be possible to treat addiction.

Some therapies, such as psychotropic drugs, could stop the brain shrinking or keep the frontal lobe working normally, they write in their paper.

Another option could be using brain-zapping technology to target this region of the brain as a “potential treatment for addiction”, the team added.

Thursday, October 25, 2007

Cheap Smokes



Lot's of folks get upset when gas prices go up. Amongst those of us who smoke we are always looking for a deal just like them folks buying gas.

And thanks to the competition to get our bucks the oligopolies that are Big Tobacco are willing to provide us with cheaper and cheaper smokes. as the State taxes and taxes them, while the Anti-Smoking lobby fumes and fusses over ways to stop us smoking.

For you smokers in Alberta, and this applies in other areas of Canada as well, here are two cheap brands.

The new kid on the block this month is John Player Standard; Blue and Silver, they have eliminated the term 'light' (due to a court ruling saying it was deceptive advertising which it is since the light brands had MORE nictone than the standard) . Which retails in some parts of Alberta for $62 a carton, GST included,whether in 20's or 25's.

The next cheapest is my favorite union label brand, Canadian. It carries the union bug for the Bakery, Confectionery, Tobacco workers & Grain Millers union. Which is $64 a carton 20's or 25's, GST included.

So while other brands for sell for anywhere from $7.50-$9 a pack before GST, these are selling for just over $6 a pack. That's like the price from a decade ago!

And the reason for these cheap brands? Why competition. The very nature of the market and capitalism.

Press release: 22 per cent of cigarettes smoked in Canada are illegal
Hot trail leads to cigarettes -ON
Sun, March 4, 2007
By JOE MATYAS, SUN MEDIA
The search for cheap smokes in the area includes smuggling and contraband
Every three weeks or so, Rita and her spouse take a half-hour drive from London to a local First Nations community to buy cheap cigarettes.
In Rita's house, every penny counts. With a modest family income, $70 for a carton of brand-name cigarettes is a steep price to pay for "one of the simple pleasures of life." On the reserve, Rita can buy 200 no-name, untaxed, machine-rolled cigarettes with filter tips in a plastic bag for about $8.


In Edmonton cigarettes still retail in bars, lounges and cigarette machines for price c$10-$12 a pack, despite a wide variety of cheaper brands being available. That' a 100% mark up! Why doesn't Jim Flaherty say something about that, eh?
After all tobacco is a domestic product and industry in Canada.

In 2001, the total revenue from tobacco exports to the USA and the E.E.C combined is over $140 million (140, 535, 000). In other words, Canada sells far more tobacco domestically than is exported abroad. Three large tobacco companies dominate the cigarette market in Canada: Imperial Tobacco Canada Limited, Rothmans, Benson & Hedges Incorporated, and JTI-Macdonald Corporation. In 1999-2000, their combined net sales was approximately $3 billion. Imperial is the largest, followed by RBH and then JTI-Macdonald. Health Canada’s Tobacco Control Programme has compiled cigarette sales data for 2001-2002 on the three major cigarette companies for each province and the total for Canada. For the year ending December 2002, the “big three” combined sales was $3.2 billion


Oh right of all the horrors of capitalism, smoking is the worst.


SEE:

Casablanca R Rated

Anti-Smoking Hypocrites

Punishing the Victim

Forget Cigarettes Ban Asbestos


nd blog posts, photos, events and more off-site about:
, , , ,
, , , , ,,,,
, ,
, , , , , ,
, , , ,




Wednesday, May 02, 2007

Anti-Smoking Hypocrites


An excellent summation of the philosophical and political morality of anti-smoking legislators;

Going into a privately-owned restaurant where smokers voluntarily associate and then complaining about the smoke makes as much sense as going to a rock concert and then complaining that they won’t turn off the loud music.



Find blog posts, photos, events and more off-site about:
, , , ,
, , , , ,,,,

, ,
, , , , , ,
, , , ,






Thursday, December 24, 2020

Light smokers may not escape nicotine addiction, study reveals

by Pennsylvania State University
DECEMBER 23, 2020
Credit: Pixabay/CC0 Public Domain

Even people who consider themselves to be casual cigarette smokers may be addicted, according to current diagnostic criteria. Researchers at Penn State College of Medicine and Duke University found that many light smokers—those who smoke one to four cigarettes per day or fewer—meet the criteria for nicotine addiction and should therefore be considered for treatment.

"In the past, some considered that only patients who smoke around 10 cigarettes per day or more were addicted, and I still hear that sometimes," said Jonathan Foulds, professor of public health sciences and psychiatry and behavioral health, Penn State. "But this study demonstrates that many lighter smokers, even those who do not smoke every day, can be addicted to cigarettes. It also suggests that we need to be more precise when we ask about cigarette smoking frequency."

According to Jason Oliver, assistant professor of psychiatry and behavioral sciences, Duke University, when assessing nicotine addiction—clinically referred to as 'tobacco use disorder'—clinicians are encouraged to fully assess the 11 criteria listed in the 5th edition of the Diagnostic and Statistical Manual (DSM-5). As a shortcut, he said, clinicians more typically ask smokers how many cigarettes they smoke per day.

"Lighter smoking is correctly perceived as less harmful than heavy smoking, but it still carries significant health risks," Oliver said. "Medical providers sometimes perceive lighter smokers as not addicted and, therefore, not in need of treatment, but this study suggests many of them may have significant difficulty quitting without assistance."

The researchers examined an existing data set from the National Institutes of Health, including more than 6,700 smokers who had been fully assessed to find out if they met the DSM-5 criteria for tobacco use disorder. They found that 85% of the daily cigarette smokers were addicted to some extent—either mild, moderate or severe addiction.

"Surprisingly, almost two thirds of those smoking only one to four cigarettes per day were addicted, and around a quarter of those smoking less than weekly were addicted," Foulds said.

The researchers found that the severity of cigarette addiction, as indicated by the number of criteria met, increased with the frequency of smoking, with 35% of those smoking one-to-four cigarettes per day and 74% of those smoking 21 cigarettes or more per day being moderately or severely addicted.

The findings appeared Dec. 22 in the American Journal of Preventive Medicine.

"This was the first time that severity of cigarette addiction has been described across the full range of cigarette use frequency," said Foulds, a Penn State Cancer Institute researcher.

Oliver added that the study highlights the high prevalence of tobacco use disorder even among those considered to be light smokers and provides a basis from which treatment can begin to target this population.

"Previous research has found that non-daily smokers are more likely than daily smokers to make a quit attempt," Oliver said. "Clinicians should ask about all smoking behavior, including non-daily smoking, as such smokers may still require treatment to successfully quit smoking. Yet, it is unclear the extent to which existing interventions are effective for light smokers. Continued efforts to identify optimal cessation approaches for this population remain an important direction for future research."


Explore further E-cigarettes 'gateway' to smoking for non-smokers

More information: Jason A. Oliver et al. Association Between Cigarette Smoking Frequency and Tobacco Use Disorder in U.S. Adults. American Journal of Preventive Medicine. Published: December 22, 2020 DOI:doi.org/10.1016/j.amepre.2020.10.019

Monday, June 10, 2024

New pathways for treating never-smoker lung cancer revealed


Precision medicine characterization through integration of genomic, transcriptomic, proteomic, and clinical data



NATIONAL RESEARCH COUNCIL OF SCIENCE & TECHNOLOGY

Overview of Genomic and Proteomic Analysis in Never-Smoking Lung Cancer Patients 

IMAGE: 

(LEFT) DISTRIBUTION OF GENDER AMONG NEVER-SMOKING LUNG CANCER PATIENTS ANALYZED IN THIS STUDY WITH PREDOMINANCE OF FEMALES.
(MIDDLE) SCREENING RESULTS FOR GENETIC MUTATIONS IN NEVER-SMOKING LUNG CANCER PATIENTS, SHOWING 15% OF PATIENTS WITH UNIDENTIFIED MUTATIONS IN LUNG TISSUE. A TOTAL OF 101 TISSUE SAMPLES UNDERWENT GENOMIC AND PROTEOMIC ANALYSIS.
(RIGHT) MOLECULAR CHARACTERIZATION OF KOREAN NEVER-SMOKING LUNG ADENOCARCINOMA USING MULTI-OMICS ANALYSIS.

view more 

CREDIT: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY(KIST)




The primary cause of lung cancer is smoking. However, the incidence of lung cancer among never-smokers has been steadily increasing, especially among women. While approximately 80% of never-smoking lung cancer patients are prescribed targeted therapies that focus on mutations in proteins such as EGFR and ALK, the remaining patients often receive cytotoxic chemotherapy with high side effects and relatively low response rates, highlighting the urgent need for targeted therapies.

Dr. Lee Cheolju's team at the Chemical Life Convergence Research Center at the Korea Institute of Science and Technology (KIST), along with Dr. Kim Seon-Young's team at the Korea Research Institute of Bioscience and Biotechnology and Dr. Han Ji-Youn's team at the National Cancer Center, have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi-omics analysis and proposed the anti-cancer drug saracatinib as a targeted therapeutic agent. Multi-omics integrates various molecular information, with proteomics presenting a particular challenge due to the need to analyze small amounts of proteins without loss, typically microgram-scale.

The research team obtained tissue samples from 101 Korean never-smoking lung cancer patients without identified treatment targets among 1,597 patients who visited the National Cancer Center over the past decade and distributed clinical information, genomic, transcriptomic, proteomic, and phosphoproteomic data to each omics analysis method for mutual referencing. Particularly, proteomic analysis measured an average of over 9,000 proteins and 5,000 phosphorylated proteins per sample using only 100 μg of protein, which is 10% of the amount required for conventional protein analysis, using isotopic labeling techniques.

Analysis of genetic mutations and cellular signaling pathways revealed that driver mutations of genes known to be associated with cancer, such as STK11 and ERBB2, were observed in the tissues of never-smoking lung cancer patients. Additionally, while the estrogen signaling pathway was found to be overexpressed, there were no significant changes in estrogen hormone receptors. Based on this, saracatinib, a sub estrogen signaling transduction protein inhibitor, showed statistically significant (p<0.01) cell death effects when applied to cells with mutations in STK11 and ERBB2 compared to the control group without such mutations.

Building on this, the research team is developing a molecular diagnostic technique for discriminating patients with specific expression of estrogen signaling pathways among never-smoking lung cancer patients. Additionally, they plan to conduct preclinical trials of saracatinib's therapeutic effects on never-smoking lung cancer animal models in collaboration with the National Cancer Center.

Dr. Lee Cheolju of KIST stated, "This successful case of discovering new therapeutic targets for refractory cancer through multi-omics analysis is based on purely domestic research and the collaborative efforts of hospitals and research institutions, which holds significant meaning. Building on this experience, we will lead the expansion of multi-omics research on human diseases."


Representative Features and Identification of Mutant Genes in Patients with Unidentified Mutations 

KIST was established in 1966 as the first government-funded research institute in Korea. KIST now strives to solve national and social challenges and secure growth engines through leading and innovative research. For more information, please visit KIST’s website at https://eng.kist.re.kr/

This research was supported by the Ministry of Science and ICT, Korea, under the KIST's main projects and the Bio-Medical Technology Development Program (2022M3H9A2096187). The research results have been published online in the latest issue of the international journal Cancer Research (IF 11.2, JCR field 10.6%).